Computational Analysis of Residue-Specific Binding Free Energies of Androgen Receptor to Ligands

Guangfeng Shao1, Jingxiao Bao1, Xiaolin Pan1

  • 1Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, Shanghai Key Laboratory of Green Chemistry and Chemical Process, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China.

Insights

Researchers quantitatively identified key hydrophobic residues in the androgen receptor (AR) ligand-binding domain (LBD) crucial for drug design. These hotspot interactions, mainly van der Waals forces, correlate well with experimental data, aiding future inhibitor development.

Area of Science:

  • Molecular pharmacology and computational chemistry.

Background:

  • The androgen receptor (AR) is a critical therapeutic target for diseases including prostate cancer, hypogonadism, and muscle wasting.
  • Understanding AR-ligand interactions is essential for developing effective treatments.

Purpose of the Study:

  • To quantitatively analyze the binding mechanisms between the AR ligand-binding domain (LBD) and fifteen different ligands.
  • To identify hotspot residues within the AR LBD that significantly contribute to ligand binding.
  • To provide insights for the rational design of novel AR inhibitors.

Main Methods:

  • Employed molecular dynamics simulations.
  • Utilized the alanine-scanning-interaction-entropy (ASIE) method to calculate quantitative free energy contributions of pocket residues.
  • Analyzed complex structures of the AR LBD with fifteen ligands.

Main Results:

  • Quantitatively identified hotspot residues within the AR LBD.
  • Found that these hotspot residues are predominantly hydrophobic.
  • Demonstrated that the primary interactions between hotspot residues and ligands are van der Waals forces.
  • Observed a good correlation between calculated total binding free energies and experimental binding data.

Conclusions:

  • The study provides a quantitative analysis of the AR-ligand binding mechanism.
  • Identified key hydrophobic residues and van der Waals interactions as critical for binding.
  • Findings offer valuable insights for the design of future AR-targeted therapeutics.

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.4K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

9.6K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.8K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.4K
Ligand Binding Sites02:40

Ligand Binding Sites

8.3K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.8K